This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n9http://linked.opendata.cz/resource/drugbank/drug/DB08323/identifier/chebi/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08323/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08323/identifier/pubchem-compound/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB08323/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08323/identifier/drugbank/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08323/identifier/chemspider/

Statements

Subject Item
n2:DB08323
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n8:DB08323 n11:DB08323
dcterms:title
3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE
adms:identifier
n6:99444794 n9:44612 n10:OHM n12:16122585 n13:17279501 n14:DB08323
n3:IUPAC-Name
n4:271B4CF1-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4CF7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4CF6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4CF3-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4CF4-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4CF5-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4CEF-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4CF0-363D-11E5-9242-09173F13E4C5 n4:271B4CED-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4CEE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4CFD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4CFE-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4CF8-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4CF9-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4CFB-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4CFA-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4CFC-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4D03-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4D05-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4D06-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4D02-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4D01-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4D04-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4CF2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4CFF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4D00-363D-11E5-9242-09173F13E4C5